This is your opportunity to be part of a global effort to improve neuroendocrine cancer care. The 2nd Survey of Challenges in Access to Diagnostics and Treatment for NET Patients (SCAN2)—launched by the International Neuroendocrine Cancer Alliance (INCA)—is gathering insights from NET patients, caregivers, and healthcare professionals to better understand the real-world challenges in diagnosis, treatment, and ongoing care.
Your perspective matters. By sharing your experiences, you can help identify gaps in access to care and shape a stronger future for the neuroendocrine cancer community.
The survey asks about:
- The availability of diagnostic tools
- The level of access to NET treatments
- The level of access to healthcare professionals
- Out-of-pocket costs of neuroendocrine cancer treatment and care
- The availability of supportive services
- The biggest healthcare issues NET/NEC patients face today
Back in 2019, the first SCAN Survey brought together the voices of more than 2,300 patients and 400+ healthcare professionals from 68 countries—making it the most comprehensive collection of NET patient data in the world. SCAN 2025 will build on that work, and your voice is essential.
👉 Take the SCAN 2025 Global Survey today (open now through November 30, 2025).
Together, we can shine a light on the challenges—and work toward solutions—for everyone living with NETs.